Poseida Therapeutics Inc. (PSTX): Price and Financial Metrics
PSTX Price/Volume Stats
| Current price | $2.61 | 52-week high | $4.27 |
| Prev. close | $2.54 | 52-week low | $1.83 |
| Day low | $2.52 | Volume | 523,900 |
| Day high | $2.64 | Avg. volume | 572,102 |
| 50-day MA | $3.02 | Dividend yield | N/A |
| 200-day MA | $3.06 | Market Cap | 253.06M |
PSTX Stock Price Chart Interactive Chart >
Poseida Therapeutics Inc. (PSTX) Company Bio
Poseida Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of non-viral gene engineering technologies for the treatment of hematological malignancies and solid tumors. Its products pipeline include autologous and allogeneic chimeric antigen receptor T cell, or CAR-T. The company was founded by Eric M. Ostertag in 2014 and is headquartered in San Diego, CA.
PSTX Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...